Social Media Intervention to Promote Smoking Treatment Utilization and Cessation among Alaska Native Smokers

Overview

About this study

The purpose of this study is to develop and pilot test a culturally relevant, Facebook delivered intervention to promote smoking treatment uptake and cessation among Alaska Native (AN) smokers.

Learn more about this study.

 

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Alaska Native person (based on self-reported race/ethnicity) and resides in Alaska
  • Age 19 years or older
  • Both men and women will be included
  • Smoked at least 1 cigarette per day over the past 7 day period
  • If other tobacco use, cigarettes are the main tobacco product used
  • Considering or willing to make a quit attempt
  • Has access to Broadband (high speed) Internet on mobile phone, at home, work, or other location.
  • Has an existing Facebook account or willing to set up an account prior to study enrollment.
  • For past 3 months not enrolled in a program or using pharmacotherapy to stop smoking

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Christi Patten, Ph.D.

Contact us for the latest status

More information

Publications

Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions